| Today's Open | $3.99 |
|---|---|
| Previous Close | $3.97 |
| Daily Range | $3.93 - $4.14 |
| 52-Week Range | $3.69 - $8.06 |
| Market Cap | $632.0M |
| P/E Ratio | -1.63 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 3,618,066 |
| Average Daily Volume | 4,942,934 |
| Current FY EPS | -$1.60 |
Sector
Healthcare
Industry
Drugs
Dendreon Corp (DNDN) Description
A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. Website: http://www.dendreon.com/
News & Commentary
One Person's Trash Is Another Person's Treasure Portfolio
A year-long exercise intent on proving that value and contrarian investing can be incredibly successful.Dendreon's Management Presents at Bank of America Merrill Lynch 2013 Health Care Conference (Transcr
Dendreon's Management Presents at Bank of America Merrill Lynch 2013 Health Care Conference (Transcript)2 Scenarios Where Buy and Hold Rarely Works
Historically, buy-and-hold investors will outperform over the long run, but it's not always as simple as it looks if you invest in these two types of companies.5 of Last Week's Biggest Losers
These five stocks posted double-digit declines this past week.Dendreon: Picking Through the Carnage
First-quarter results for the prostate cancer drug maker were even uglier than anticipated.
There were a lot of things happening in the market this past week.
DNDN's Top Competitors
(1.01%)
(0.63%)
(2.44%)
(-0.50%)